- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Hewlett-Packard scanner gains FDA okay
Ultrasound vendor Hewlett-Packard apparently has a new scannerwaiting in the wings. The Andover, MA, company gained Food andDrug Administration 510(k) clearance in August for a new diagnosticultrasound system. HP officials are not ready to make a
Ultrasound vendor Hewlett-Packard apparently has a new scannerwaiting in the wings. The Andover, MA, company gained Food andDrug Administration 510(k) clearance in August for a new diagnosticultrasound system. HP officials are not ready to make a publicintroduction of the scanner, however, and declined to providedetails about the system.
HP is the market leader in cardiac ultrasound and has operatedin the radiology market since 1993 through a joint R&D andmanufacturing agreement with Philips Medical Systems. The alliancedeveloped the Philips sonoDiagnost 800, a moderately priced colorflow system introduced in 1994 (SCAN 12/14/94).
HP's lead product in cardiology is Sonos 2500, which was introducedat the American Society of Echocardiography meeting in 1994 (SCAN6/29/94).
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
